nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0684	0.0908	CbGbCtD
Methazolamide—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0518	0.0688	CbGbCtD
Methazolamide—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0272	0.0362	CbGbCtD
Methazolamide—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.025	0.0332	CbGbCtD
Methazolamide—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0243	0.0323	CbGbCtD
Methazolamide—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0229	0.0304	CbGbCtD
Methazolamide—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0211	0.028	CbGbCtD
Methazolamide—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0207	0.0275	CbGbCtD
Methazolamide—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0207	0.0275	CbGbCtD
Methazolamide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0202	0.0269	CbGbCtD
Methazolamide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.019	0.0253	CbGbCtD
Methazolamide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.019	0.0253	CbGbCtD
Methazolamide—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0185	0.0246	CbGbCtD
Methazolamide—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0179	0.0237	CbGbCtD
Methazolamide—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0174	0.0231	CbGbCtD
Methazolamide—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0174	0.0231	CbGbCtD
Methazolamide—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0173	0.023	CbGbCtD
Methazolamide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0172	0.0228	CbGbCtD
Methazolamide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0172	0.0228	CbGbCtD
Methazolamide—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0157	0.0209	CbGbCtD
Methazolamide—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0157	0.0209	CbGbCtD
Methazolamide—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0157	0.0208	CbGbCtD
Methazolamide—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0157	0.0208	CbGbCtD
Methazolamide—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.015	0.02	CbGbCtD
Methazolamide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0148	0.0197	CbGbCtD
Methazolamide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0144	0.0191	CbGbCtD
Methazolamide—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0136	0.018	CbGbCtD
Methazolamide—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0132	0.0175	CbGbCtD
Methazolamide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.013	0.0173	CbGbCtD
Methazolamide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.013	0.0173	CbGbCtD
Methazolamide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0125	0.0166	CbGbCtD
Methazolamide—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0119	0.0158	CbGbCtD
Methazolamide—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0119	0.0158	CbGbCtD
Methazolamide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0118	0.0156	CbGbCtD
Methazolamide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0111	0.0147	CbGbCtD
Methazolamide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0111	0.0147	CbGbCtD
Methazolamide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.01	0.0133	CbGbCtD
Methazolamide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.01	0.0133	CbGbCtD
Methazolamide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00863	0.0115	CbGbCtD
Methazolamide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00838	0.0111	CbGbCtD
Methazolamide—CA6—saliva—acquired immunodeficiency syndrome	0.00833	0.142	CbGeAlD
Methazolamide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00758	0.0101	CbGbCtD
Methazolamide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00758	0.0101	CbGbCtD
Methazolamide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00727	0.00965	CbGbCtD
Methazolamide—CA1—nerve—acquired immunodeficiency syndrome	0.00255	0.0435	CbGeAlD
Methazolamide—CA4—nerve—acquired immunodeficiency syndrome	0.00199	0.034	CbGeAlD
Methazolamide—CA1—blood plasma—acquired immunodeficiency syndrome	0.00193	0.0329	CbGeAlD
Methazolamide—CA7—digestive system—acquired immunodeficiency syndrome	0.00144	0.0246	CbGeAlD
Methazolamide—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00136	0.0233	CbGeAlD
Methazolamide—CA9—digestive system—acquired immunodeficiency syndrome	0.00126	0.0216	CbGeAlD
Methazolamide—CA2—blood plasma—acquired immunodeficiency syndrome	0.00125	0.0213	CbGeAlD
Methazolamide—CA14—spinal cord—acquired immunodeficiency syndrome	0.0011	0.0188	CbGeAlD
Methazolamide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00106	0.018	CbGeAlD
Methazolamide—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.001	0.0171	CbGeAlD
Methazolamide—CA12—digestive system—acquired immunodeficiency syndrome	0.000935	0.016	CbGeAlD
Methazolamide—CA7—brain—acquired immunodeficiency syndrome	0.000851	0.0145	CbGeAlD
Methazolamide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000806	0.0138	CbGeAlD
Methazolamide—CA5B—blood—acquired immunodeficiency syndrome	0.000799	0.0137	CbGeAlD
Methazolamide—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000793	0.0135	CbGeAlD
Methazolamide—CA12—lung—acquired immunodeficiency syndrome	0.000781	0.0133	CbGeAlD
Methazolamide—CA1—lymphoid tissue—acquired immunodeficiency syndrome	0.00075	0.0128	CbGeAlD
Methazolamide—CA1—digestive system—acquired immunodeficiency syndrome	0.000741	0.0127	CbGeAlD
Methazolamide—CA5B—vagina—acquired immunodeficiency syndrome	0.000741	0.0127	CbGeAlD
Methazolamide—CA12—nervous system—acquired immunodeficiency syndrome	0.000724	0.0124	CbGeAlD
Methazolamide—CA14—brain—acquired immunodeficiency syndrome	0.000709	0.0121	CbGeAlD
Methazolamide—CA1—blood—acquired immunodeficiency syndrome	0.000706	0.0121	CbGeAlD
Methazolamide—CA5B—lung—acquired immunodeficiency syndrome	0.000701	0.012	CbGeAlD
Methazolamide—CA12—central nervous system—acquired immunodeficiency syndrome	0.000697	0.0119	CbGeAlD
Methazolamide—CA2—retina—acquired immunodeficiency syndrome	0.000684	0.0117	CbGeAlD
Methazolamide—CA1—bone marrow—acquired immunodeficiency syndrome	0.000683	0.0117	CbGeAlD
Methazolamide—CA1—spinal cord—acquired immunodeficiency syndrome	0.00068	0.0116	CbGeAlD
Methazolamide—CA5B—nervous system—acquired immunodeficiency syndrome	0.000649	0.0111	CbGeAlD
Methazolamide—CA5B—central nervous system—acquired immunodeficiency syndrome	0.000625	0.0107	CbGeAlD
Methazolamide—CA1—lung—acquired immunodeficiency syndrome	0.000619	0.0106	CbGeAlD
Methazolamide—SLC22A6—brain—acquired immunodeficiency syndrome	0.000617	0.0105	CbGeAlD
Methazolamide—CA2—skin of body—acquired immunodeficiency syndrome	0.0006	0.0103	CbGeAlD
Methazolamide—CA4—digestive system—acquired immunodeficiency syndrome	0.000579	0.00989	CbGeAlD
Methazolamide—CA1—nervous system—acquired immunodeficiency syndrome	0.000573	0.00979	CbGeAlD
Methazolamide—CA12—brain—acquired immunodeficiency syndrome	0.000553	0.00944	CbGeAlD
Methazolamide—CA4—blood—acquired immunodeficiency syndrome	0.000552	0.00942	CbGeAlD
Methazolamide—CA1—central nervous system—acquired immunodeficiency syndrome	0.000552	0.00942	CbGeAlD
Methazolamide—CA4—bone marrow—acquired immunodeficiency syndrome	0.000534	0.00912	CbGeAlD
Methazolamide—CA4—spinal cord—acquired immunodeficiency syndrome	0.000532	0.00908	CbGeAlD
Methazolamide—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000524	0.00895	CbGeAlD
Methazolamide—CYP2C19—blood—acquired immunodeficiency syndrome	0.000499	0.00853	CbGeAlD
Methazolamide—CA5B—brain—acquired immunodeficiency syndrome	0.000496	0.00847	CbGeAlD
Methazolamide—CA2—lymphoid tissue—acquired immunodeficiency syndrome	0.000486	0.0083	CbGeAlD
Methazolamide—CA4—lung—acquired immunodeficiency syndrome	0.000484	0.00826	CbGeAlD
Methazolamide—CA2—digestive system—acquired immunodeficiency syndrome	0.00048	0.0082	CbGeAlD
Methazolamide—CA5B—lymph node—acquired immunodeficiency syndrome	0.000479	0.00818	CbGeAlD
Methazolamide—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000463	0.0079	CbGeAlD
Methazolamide—CA2—blood—acquired immunodeficiency syndrome	0.000458	0.00781	CbGeAlD
Methazolamide—CA4—nervous system—acquired immunodeficiency syndrome	0.000448	0.00765	CbGeAlD
Methazolamide—CA2—bone marrow—acquired immunodeficiency syndrome	0.000443	0.00756	CbGeAlD
Methazolamide—CA2—spinal cord—acquired immunodeficiency syndrome	0.000441	0.00753	CbGeAlD
Methazolamide—CA1—brain—acquired immunodeficiency syndrome	0.000438	0.00748	CbGeAlD
Methazolamide—CA4—central nervous system—acquired immunodeficiency syndrome	0.000431	0.00736	CbGeAlD
Methazolamide—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000428	0.00227	CcSEcCtD
Methazolamide—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000428	0.00227	CcSEcCtD
Methazolamide—CA2—vagina—acquired immunodeficiency syndrome	0.000424	0.00724	CbGeAlD
Methazolamide—CA1—lymph node—acquired immunodeficiency syndrome	0.000423	0.00723	CbGeAlD
Methazolamide—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000422	0.00224	CcSEcCtD
Methazolamide—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.000418	0.00221	CcSEcCtD
Methazolamide—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.000415	0.0022	CcSEcCtD
Methazolamide—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000414	0.00219	CcSEcCtD
Methazolamide—Ill-defined disorder—Indinavir—acquired immunodeficiency syndrome	0.000413	0.00219	CcSEcCtD
Methazolamide—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.000412	0.00218	CcSEcCtD
Methazolamide—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000409	0.00217	CcSEcCtD
Methazolamide—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000408	0.00216	CcSEcCtD
Methazolamide—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000407	0.00216	CcSEcCtD
Methazolamide—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000406	0.00694	CbGeAlD
Methazolamide—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.000405	0.00214	CcSEcCtD
Methazolamide—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000405	0.00214	CcSEcCtD
Methazolamide—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000404	0.00214	CcSEcCtD
Methazolamide—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.000404	0.00214	CcSEcCtD
Methazolamide—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000403	0.00213	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000402	0.00213	CcSEcCtD
Methazolamide—Malaise—Indinavir—acquired immunodeficiency syndrome	0.000401	0.00213	CcSEcCtD
Methazolamide—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000401	0.00213	CcSEcCtD
Methazolamide—CA2—lung—acquired immunodeficiency syndrome	0.000401	0.00685	CbGeAlD
Methazolamide—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000401	0.00212	CcSEcCtD
Methazolamide—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.0004	0.00212	CcSEcCtD
Methazolamide—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.0004	0.00212	CcSEcCtD
Methazolamide—Tinnitus—Ritonavir—acquired immunodeficiency syndrome	0.000399	0.00211	CcSEcCtD
Methazolamide—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000398	0.00211	CcSEcCtD
Methazolamide—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000397	0.0021	CcSEcCtD
Methazolamide—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000396	0.0021	CcSEcCtD
Methazolamide—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.000394	0.00209	CcSEcCtD
Methazolamide—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.000394	0.00209	CcSEcCtD
Methazolamide—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000392	0.00208	CcSEcCtD
Methazolamide—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000391	0.00207	CcSEcCtD
Methazolamide—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000391	0.00207	CcSEcCtD
Methazolamide—Ill-defined disorder—Efavirenz—acquired immunodeficiency syndrome	0.00039	0.00207	CcSEcCtD
Methazolamide—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.00039	0.00666	CbGeAlD
Methazolamide—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000389	0.00206	CcSEcCtD
Methazolamide—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000389	0.00206	CcSEcCtD
Methazolamide—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000389	0.00206	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000388	0.00206	CcSEcCtD
Methazolamide—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000388	0.00205	CcSEcCtD
Methazolamide—CYP2C9—blood—acquired immunodeficiency syndrome	0.000387	0.00661	CbGeAlD
Methazolamide—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000385	0.00658	CbGeAlD
Methazolamide—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000385	0.00204	CcSEcCtD
Methazolamide—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.000384	0.00203	CcSEcCtD
Methazolamide—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000384	0.00203	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000382	0.00203	CcSEcCtD
Methazolamide—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000382	0.00202	CcSEcCtD
Methazolamide—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.000379	0.00201	CcSEcCtD
Methazolamide—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000378	0.002	CcSEcCtD
Methazolamide—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.000374	0.00198	CcSEcCtD
Methazolamide—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.000373	0.00198	CcSEcCtD
Methazolamide—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000372	0.00197	CcSEcCtD
Methazolamide—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000372	0.00197	CcSEcCtD
Methazolamide—CA2—nervous system—acquired immunodeficiency syndrome	0.000371	0.00634	CbGeAlD
Methazolamide—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000371	0.00197	CcSEcCtD
Methazolamide—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000371	0.00197	CcSEcCtD
Methazolamide—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00037	0.00196	CcSEcCtD
Methazolamide—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000368	0.00195	CcSEcCtD
Methazolamide—CYP2E1—blood—acquired immunodeficiency syndrome	0.000367	0.00626	CbGeAlD
Methazolamide—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000365	0.00193	CcSEcCtD
Methazolamide—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000364	0.00193	CcSEcCtD
Methazolamide—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000364	0.00193	CcSEcCtD
Methazolamide—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000363	0.00193	CcSEcCtD
Methazolamide—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000363	0.00192	CcSEcCtD
Methazolamide—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000362	0.00192	CcSEcCtD
Methazolamide—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000361	0.00191	CcSEcCtD
Methazolamide—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00036	0.00191	CcSEcCtD
Methazolamide—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000358	0.0019	CcSEcCtD
Methazolamide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000358	0.0019	CcSEcCtD
Methazolamide—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000358	0.0019	CcSEcCtD
Methazolamide—CA2—central nervous system—acquired immunodeficiency syndrome	0.000358	0.00611	CbGeAlD
Methazolamide—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000357	0.00189	CcSEcCtD
Methazolamide—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000356	0.00189	CcSEcCtD
Methazolamide—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000356	0.00189	CcSEcCtD
Methazolamide—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000355	0.00188	CcSEcCtD
Methazolamide—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000354	0.00188	CcSEcCtD
Methazolamide—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000354	0.00187	CcSEcCtD
Methazolamide—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000353	0.00604	CbGeAlD
Methazolamide—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000352	0.00186	CcSEcCtD
Methazolamide—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000351	0.00186	CcSEcCtD
Methazolamide—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000351	0.00186	CcSEcCtD
Methazolamide—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00035	0.00185	CcSEcCtD
Methazolamide—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000347	0.00184	CcSEcCtD
Methazolamide—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000346	0.00183	CcSEcCtD
Methazolamide—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000346	0.00183	CcSEcCtD
Methazolamide—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000345	0.00183	CcSEcCtD
Methazolamide—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000344	0.00182	CcSEcCtD
Methazolamide—CA4—brain—acquired immunodeficiency syndrome	0.000342	0.00585	CbGeAlD
Methazolamide—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00034	0.0018	CcSEcCtD
Methazolamide—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000339	0.00179	CcSEcCtD
Methazolamide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000337	0.00179	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000337	0.00179	CcSEcCtD
Methazolamide—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000337	0.00178	CcSEcCtD
Methazolamide—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000336	0.00178	CcSEcCtD
Methazolamide—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000335	0.00177	CcSEcCtD
Methazolamide—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000334	0.00177	CcSEcCtD
Methazolamide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000334	0.00177	CcSEcCtD
Methazolamide—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000333	0.00176	CcSEcCtD
Methazolamide—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000332	0.00176	CcSEcCtD
Methazolamide—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000331	0.00175	CcSEcCtD
Methazolamide—CA4—lymph node—acquired immunodeficiency syndrome	0.000331	0.00565	CbGeAlD
Methazolamide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000329	0.00174	CcSEcCtD
Methazolamide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.00173	CcSEcCtD
Methazolamide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000326	0.00173	CcSEcCtD
Methazolamide—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000326	0.00173	CcSEcCtD
Methazolamide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000326	0.00173	CcSEcCtD
Methazolamide—Headache—Didanosine—acquired immunodeficiency syndrome	0.000324	0.00172	CcSEcCtD
Methazolamide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000323	0.00171	CcSEcCtD
Methazolamide—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000323	0.00171	CcSEcCtD
Methazolamide—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000323	0.00171	CcSEcCtD
Methazolamide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000322	0.00171	CcSEcCtD
Methazolamide—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000322	0.00171	CcSEcCtD
Methazolamide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000322	0.00171	CcSEcCtD
Methazolamide—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000322	0.00171	CcSEcCtD
Methazolamide—CYP2E1—lung—acquired immunodeficiency syndrome	0.000322	0.00549	CbGeAlD
Methazolamide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000321	0.0017	CcSEcCtD
Methazolamide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00032	0.00169	CcSEcCtD
Methazolamide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000319	0.00169	CcSEcCtD
Methazolamide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000318	0.00168	CcSEcCtD
Methazolamide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000317	0.00168	CcSEcCtD
Methazolamide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000316	0.00167	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000314	0.00166	CcSEcCtD
Methazolamide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000313	0.00166	CcSEcCtD
Methazolamide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000313	0.00166	CcSEcCtD
Methazolamide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000313	0.00166	CcSEcCtD
Methazolamide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00031	0.00164	CcSEcCtD
Methazolamide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00031	0.00164	CcSEcCtD
Methazolamide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.00031	0.00529	CbGeAlD
Methazolamide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000309	0.00164	CcSEcCtD
Methazolamide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000308	0.00163	CcSEcCtD
Methazolamide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000308	0.00163	CcSEcCtD
Methazolamide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000308	0.00163	CcSEcCtD
Methazolamide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000308	0.00163	CcSEcCtD
Methazolamide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000308	0.00163	CcSEcCtD
Methazolamide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000307	0.00163	CcSEcCtD
Methazolamide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000306	0.00162	CcSEcCtD
Methazolamide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000306	0.00162	CcSEcCtD
Methazolamide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000305	0.00162	CcSEcCtD
Methazolamide—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000305	0.00521	CbGeAlD
Methazolamide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000303	0.00161	CcSEcCtD
Methazolamide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000302	0.0016	CcSEcCtD
Methazolamide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000301	0.0016	CcSEcCtD
Methazolamide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000299	0.00159	CcSEcCtD
Methazolamide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000298	0.00158	CcSEcCtD
Methazolamide—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000298	0.00509	CbGeAlD
Methazolamide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000296	0.00157	CcSEcCtD
Methazolamide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000296	0.00157	CcSEcCtD
Methazolamide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000296	0.00157	CcSEcCtD
Methazolamide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000296	0.00157	CcSEcCtD
Methazolamide—CYP3A4—blood—acquired immunodeficiency syndrome	0.000295	0.00504	CbGeAlD
Methazolamide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000295	0.00156	CcSEcCtD
Methazolamide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000295	0.00156	CcSEcCtD
Methazolamide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000294	0.00156	CcSEcCtD
Methazolamide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000293	0.00155	CcSEcCtD
Methazolamide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00155	CcSEcCtD
Methazolamide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000292	0.00155	CcSEcCtD
Methazolamide—CYP2D6—blood—acquired immunodeficiency syndrome	0.00029	0.00496	CbGeAlD
Methazolamide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.00153	CcSEcCtD
Methazolamide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000289	0.00153	CcSEcCtD
Methazolamide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000289	0.00153	CcSEcCtD
Methazolamide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000287	0.00152	CcSEcCtD
Methazolamide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000287	0.00152	CcSEcCtD
Methazolamide—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000287	0.0049	CbGeAlD
Methazolamide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000287	0.00152	CcSEcCtD
Methazolamide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000286	0.00151	CcSEcCtD
Methazolamide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000286	0.00151	CcSEcCtD
Methazolamide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000284	0.00151	CcSEcCtD
Methazolamide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000284	0.0015	CcSEcCtD
Methazolamide—CA2—brain—acquired immunodeficiency syndrome	0.000284	0.00485	CbGeAlD
Methazolamide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000284	0.0015	CcSEcCtD
Methazolamide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000283	0.0015	CcSEcCtD
Methazolamide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000283	0.0015	CcSEcCtD
Methazolamide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000283	0.0015	CcSEcCtD
Methazolamide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000283	0.0015	CcSEcCtD
Methazolamide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000282	0.0015	CcSEcCtD
Methazolamide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000282	0.00149	CcSEcCtD
Methazolamide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000282	0.00149	CcSEcCtD
Methazolamide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000281	0.00149	CcSEcCtD
Methazolamide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00028	0.00149	CcSEcCtD
Methazolamide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000279	0.00148	CcSEcCtD
Methazolamide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000279	0.00148	CcSEcCtD
Methazolamide—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.00148	CcSEcCtD
Methazolamide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.00148	CcSEcCtD
Methazolamide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000277	0.00147	CcSEcCtD
Methazolamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000277	0.00147	CcSEcCtD
Methazolamide—CA2—lymph node—acquired immunodeficiency syndrome	0.000274	0.00468	CbGeAlD
Methazolamide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000273	0.00145	CcSEcCtD
Methazolamide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.00144	CcSEcCtD
Methazolamide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000271	0.00144	CcSEcCtD
Methazolamide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000271	0.00143	CcSEcCtD
Methazolamide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00143	CcSEcCtD
Methazolamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000268	0.00142	CcSEcCtD
Methazolamide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.00142	CcSEcCtD
Methazolamide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000267	0.00142	CcSEcCtD
Methazolamide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000267	0.00141	CcSEcCtD
Methazolamide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.00141	CcSEcCtD
Methazolamide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000264	0.0014	CcSEcCtD
Methazolamide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000263	0.00139	CcSEcCtD
Methazolamide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.00139	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000262	0.00139	CcSEcCtD
Methazolamide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000262	0.00139	CcSEcCtD
Methazolamide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.00138	CcSEcCtD
Methazolamide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000261	0.00138	CcSEcCtD
Methazolamide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00138	CcSEcCtD
Methazolamide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.00138	CcSEcCtD
Methazolamide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.00136	CcSEcCtD
Methazolamide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.00135	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000252	0.00134	CcSEcCtD
Methazolamide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000252	0.00134	CcSEcCtD
Methazolamide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00025	0.00133	CcSEcCtD
Methazolamide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00025	0.00133	CcSEcCtD
Methazolamide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000249	0.00132	CcSEcCtD
Methazolamide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000248	0.00132	CcSEcCtD
Methazolamide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.00131	CcSEcCtD
Methazolamide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000246	0.00131	CcSEcCtD
Methazolamide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000246	0.0013	CcSEcCtD
Methazolamide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000246	0.0013	CcSEcCtD
Methazolamide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.0013	CcSEcCtD
Methazolamide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000245	0.0013	CcSEcCtD
Methazolamide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.00128	CcSEcCtD
Methazolamide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.00128	CcSEcCtD
Methazolamide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.00128	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000241	0.00128	CcSEcCtD
Methazolamide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00024	0.00127	CcSEcCtD
Methazolamide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00127	CcSEcCtD
Methazolamide—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00024	0.00409	CbGeAlD
Methazolamide—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000236	0.00403	CbGeAlD
Methazolamide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000236	0.00125	CcSEcCtD
Methazolamide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.00124	CcSEcCtD
Methazolamide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.00123	CcSEcCtD
Methazolamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000232	0.00123	CcSEcCtD
Methazolamide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00122	CcSEcCtD
Methazolamide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000231	0.00122	CcSEcCtD
Methazolamide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000231	0.00394	CbGeAlD
Methazolamide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.00122	CcSEcCtD
Methazolamide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000229	0.00121	CcSEcCtD
Methazolamide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000229	0.00121	CcSEcCtD
Methazolamide—CYP2E1—brain—acquired immunodeficiency syndrome	0.000228	0.00389	CbGeAlD
Methazolamide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000228	0.00121	CcSEcCtD
Methazolamide—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000227	0.00388	CbGeAlD
Methazolamide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.00119	CcSEcCtD
Methazolamide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00117	CcSEcCtD
Methazolamide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.00117	CcSEcCtD
Methazolamide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000218	0.00116	CcSEcCtD
Methazolamide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.00115	CcSEcCtD
Methazolamide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000216	0.00115	CcSEcCtD
Methazolamide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000216	0.00115	CcSEcCtD
Methazolamide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000216	0.00114	CcSEcCtD
Methazolamide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000215	0.00114	CcSEcCtD
Methazolamide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.00111	CcSEcCtD
Methazolamide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000209	0.00111	CcSEcCtD
Methazolamide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.0011	CcSEcCtD
Methazolamide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.0011	CcSEcCtD
Methazolamide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.0011	CcSEcCtD
Methazolamide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000206	0.00109	CcSEcCtD
Methazolamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.00108	CcSEcCtD
Methazolamide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.00106	CcSEcCtD
Methazolamide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.00106	CcSEcCtD
Methazolamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.00103	CcSEcCtD
Methazolamide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.00102	CcSEcCtD
Methazolamide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.00101	CcSEcCtD
Methazolamide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.00101	CcSEcCtD
Methazolamide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.00101	CcSEcCtD
Methazolamide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.00101	CcSEcCtD
Methazolamide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000985	CcSEcCtD
Methazolamide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.000977	CcSEcCtD
Methazolamide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.000976	CcSEcCtD
Methazolamide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.00097	CcSEcCtD
Methazolamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.000956	CcSEcCtD
Methazolamide—CYP2D6—brain—acquired immunodeficiency syndrome	0.00018	0.00308	CbGeAlD
Methazolamide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000939	CcSEcCtD
Methazolamide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000932	CcSEcCtD
Methazolamide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000931	CcSEcCtD
Methazolamide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.000926	CcSEcCtD
Methazolamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.00092	CcSEcCtD
Methazolamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000878	CcSEcCtD
